Related Parties (Details narrative) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Jun. 30, 2023	Mar. 21, 2023	Dec. 31, 2022
Common stock shares issued	5,367,674		2,161,950
Common stock conversion price	$ 3.20
Convertible Notes	7,856
Convertible Promissory Notes	$ 25.1
Interest accrued	$ 13.9
Business Combination, Description	Mr. Jenkins and his affiliates received 1,325.838 shares of Series X Convertible Preferred Stock in the merger, and Mr. Jenkins’ adult children received 1,284.344 shares of Series X Convertible Preferred Stock in the merger, all in exchange for their equity interests in Catheter in accordance with the merger exchange ratio.
Accrued expenses	$ 1.4
Mr. Jenkins [Member]
Common stock shares issued		991,828
Exercise price	$ 0.59
Remaining number of options exercise price	$ 2.02
Conversion of stock description	conversion of 991.828 shares of Series X Convertible Preferred Stock, and 235,320 shares of common stock to his adult children upon conversion of 235.320 shares of Series X Convertible Preferred Stock.
Accrued expenses	$ 1.1
Options to purchase	144,169
Number of options	140,816
Remaining number of options	3,353